HOME PRODUCTS SERVICES COMPANY CONTACT FAQ

Infectious Bone Diseases

Subscribe to New Research on Infectious Bone Diseases

Bone diseases caused by pathogenic microorganisms.

Also Known As:

Bone Diseases, Infectious; Bone Disease, Infectious; Disease, Infectious Bone; Diseases, Infectious Bone; Infectious Bone Disease

Networked: 2 relevant articles (1 outcomes, 1 trials/studies)

Relationship Network

Disease Context: Research Results

Bacterial Infections and Mycoses
- Infection: 328407
  - Infectious Bone Diseases: 2
Musculoskeletal Diseases: 179
- Bone Diseases: 3566
  - Infectious Bone Diseases: 2

Related Diseases

1.	Osteomyelitis

Experts

1.	Bozkurt, Fatih: 1 article (11/2013)
2.	Erdemli, Ozge: 1 article (11/2013)
3.	Yaprakci, Volkan: 1 article (11/2013)
4.	Keskin, Dilek: 1 article (11/2013)
5.	Kayabolen, Alisan: 1 article (11/2013)
6.	Tezcaner, Aysen: 1 article (11/2013)
7.	Birnbaum, Klaus: 1 article (01/2013)
8.	Lühmann, Markus: 1 article (01/2013)
9.	Maier, Gerrit Steffen: 1 article (01/2013)
10.	Niedhart, Christopher: 1 article (01/2013)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Infectious Bone Diseases:

1.	beta-tricalcium phosphateIBA 01/01/2013 - "Cerasorb(®) and Cersorb M(®) may represent a new treatment option in osteomyelitis and infectious bone disease."
2.	Calcium Sulfate (Alabaster)IBA 11/01/2013 - "This study aimed to investigate the release of cefuroxime axetil (CF) and calcium from poly(ε-caprolactone) (PCL)-calcium sulfate (CaS) implants (PCL:CaS 2:1-10% CF; PCL:CaS 2:1-20% CF; PCL:CaS 1:1-10% CF) for treating infectious bone diseases. "
3.	CalciumIBA 11/01/2013 - "This study aimed to investigate the release of cefuroxime axetil (CF) and calcium from poly(ε-caprolactone) (PCL)-calcium sulfate (CaS) implants (PCL:CaS 2:1-10% CF; PCL:CaS 2:1-20% CF; PCL:CaS 1:1-10% CF) for treating infectious bone diseases. "
4.	caprolactoneIBA 11/01/2013 - "This study aimed to investigate the release of cefuroxime axetil (CF) and calcium from poly(ε-caprolactone) (PCL)-calcium sulfate (CaS) implants (PCL:CaS 2:1-10% CF; PCL:CaS 2:1-20% CF; PCL:CaS 1:1-10% CF) for treating infectious bone diseases. "
5.	cefuroxime axetil (Ceftin)FDA LinkGeneric 11/01/2013 - "This study aimed to investigate the release of cefuroxime axetil (CF) and calcium from poly(ε-caprolactone) (PCL)-calcium sulfate (CaS) implants (PCL:CaS 2:1-10% CF; PCL:CaS 2:1-20% CF; PCL:CaS 1:1-10% CF) for treating infectious bone diseases. "
6.	Anti-Bacterial Agents (Antibiotics)IBA 01/01/2013 - "Beta tricalciumphosphate pellets loaded with individualized antibiotics may represent novel options in the treatment of osteomyelitis and infectious bone disease. "